387 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
drug products, drug substances, and other materials on a timely basis and in sufficient amounts; risks relating to rigorous regulatory requirements
8-K
EX-2.1
rq67s8l40zlfw
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
i1mf op5euizr4
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
2geztif3135fa3xhr
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
qar1q75du44dxrnnl20
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
EX-1.1
uq5u5g
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-99.1
ta19hhcd4k
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
ff1g1ew97fobqu01
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
qb4br4y 524
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm